Open Access

RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue

  • Authors:
    • Victoria Grèze
    • Justyna Kanold
    • Fanny Chambon
    • Pascale Halle
    • Anne‑Sophie Gremeau
    • Nathalie Rives
    • Nadège Rouel
    • Bruno Pereira
    • Andrei Tchirkov
    • Florence Brugnon
  • View Affiliations

  • Published online on: May 24, 2017     https://doi.org/10.3892/ol.2017.6238
  • Pages: 860-866
  • Copyright: © Grèze et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Neuroblastoma (NB) is the most common type of extracranial solid tumor in children with a high prevalence in toddlers. For childhood cancer survivors, preservation of reproductive potential is an important factor for quality of life. The optimization of NB minimal residual disease (MRD) detection in testicular tissue is crucial to evaluate the risk of malignant cell reintroduction. The first step in the present study was to assess the accuracy of reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) to detect tyrosine hydroxylase (TH), paired‑like homeobox 2b (PHOX2B) and doublecortin (DCX) mRNA expression in frozen/thawed testicular tissues of patients with non‑obstructive azoospermia (NOA) contaminated (in vitro model) with an increasing number of IMR‑32 and SK‑N‑SH NB cells. Testicular tissues were frozen by slow or snap freezing. The second step was to determine the expression levels of these markers in testicular samples from 4 pre‑pubertal males (2 with stage IV NB and 2 with non‑NB malignancy). The yield of extracted RNA was similar in testicular samples frozen by slow or snap freezing. In the in vitro model, TH and DCX transcripts were detected in uncontaminated testicular tissues, whereas PHOX2B mRNA was not detected. There was a strong positive association between the number of NB cells used for contamination and PHOX2B transcript levels. For IMR‑32 and SK‑N‑SH NB cell lines, specificity and sensitivity rates of detection were 100% for PHOX2B following in vitro contamination with 10 tumor cells. In testicular samples from pre‑pubertal males with and without NB, PHOX2B mRNA expression was not observed, but high expression levels of TH and DCX mRNA were detected, which were similar to expression detected in the in vitro model. Among the markers used in blood and bone marrow for NB MRD studies, the detection of PHOX2B transcripts by RT‑qPCR may provide an accurate assessment of NB cells in testicular tissues from males who require fertility preservation.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 14 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Grèze V, Kanold J, Chambon F, Halle P, Gremeau AS, Rives N, Rouel N, Pereira B, Tchirkov A, Brugnon F, Brugnon F, et al: RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue. Oncol Lett 14: 860-866, 2017
APA
Grèze, V., Kanold, J., Chambon, F., Halle, P., Gremeau, A., Rives, N. ... Brugnon, F. (2017). RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue. Oncology Letters, 14, 860-866. https://doi.org/10.3892/ol.2017.6238
MLA
Grèze, V., Kanold, J., Chambon, F., Halle, P., Gremeau, A., Rives, N., Rouel, N., Pereira, B., Tchirkov, A., Brugnon, F."RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue". Oncology Letters 14.1 (2017): 860-866.
Chicago
Grèze, V., Kanold, J., Chambon, F., Halle, P., Gremeau, A., Rives, N., Rouel, N., Pereira, B., Tchirkov, A., Brugnon, F."RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue". Oncology Letters 14, no. 1 (2017): 860-866. https://doi.org/10.3892/ol.2017.6238